To examine if CXCR4 was upregulated in malignant monocytes compared to healthy monocytes, we compared the monocyte-like cells, which have a confirmed mutation in targeted sequences known to be mutated in AML, to healthy, non-mutated monocytes from the same donors. The gene discussed is CXCR4; the disease is acute myeloid leukemia.